Anal cancer poses a significant health burden on people with HIV (PWH), due to the increased risk associated with compromised immune systems and increased barriers to accessing regular screenings healthcare services. HIV infection weakens the body’s ability to fight off human papillomavirus (HPV), a primary cause of anal cancer, leading to higher incidence rates among PWH. The intersection of HIV-related stigma and the stigma surrounding anal cancer can also contribute to delays in diagnosis and treatment.
In this presentation, Dr. Alan Nyitray of the Medical College of Wisconsin delve into the innovative approach of an anal cancer self-sampling study. The findings underscore the promise of homebased self-sampling as a powerful tool in early detection and prevention efforts for anal cancer. Join us on May 22 as we explore the impact of this study in empowering individuals to prioritize their well-being and combat this often overlooked health concern.
Presenter
Alan Nyitray, PhD | he/they
Associate Professor, Department of Psychiatry and Behavioral Medicine
Center for AIDS Intervention Research (CAIR)
MCW Cancer Center Medical College of Wisconsin
Milwaukee, Wisconsin
Target audience
HIV, infectious disease, oncology, and other health care providers involved in anal cancer prevention and treatment
Learning Objectives
- Review epidemiology of anal cancer
- Discuss Prevent Anal Cancer (PAC) Self-Swab Study Results
- Self-sampling specimen adequacy
- Individuals’ preference and acceptance of anal self-sampling
- Home-based self-sampling, clinical follow up, and disease detection
- Biomarkers
